• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非病毒载体对基因活性的高效内吞作用的调控。

Regulation of endocytosis by non-viral vectors for efficient gene activity.

出版信息

J Biomed Nanotechnol. 2014 Jan;10(1):67-80. doi: 10.1166/jbn.2014.1682.

DOI:10.1166/jbn.2014.1682
PMID:24724499
Abstract

Non-viral carriers, able to regulate cellular uptake pathways are becoming promising vectors for efficient gene transfer into cells because the intracellular processing of gene is strongly determined by the internalization pathways and subsequent intracellular routes. The intracellular processing of gene can be directed either to digestive or non-digestive way depending on the endocytosis mechanism. Enormous attempts have been made to bypass or avoid the digestive way of lysosomal degradation for meaningful delivery of therapeutic genes at the target site. This review describes an updated information regarding regulation of endocytosis pathways in consequence with the cellular trafficking and the determinant factors of the initial mode of internalization route for rational design of non-viral gene carriers. Firstly, we describe various nonviral gene vectors and the key barriers to non-viral gene transfer. Secondly, various major endocytosis pathways and their significance in developing non-viral gene carriers are discussed. Thirdly, various factors that potentially regulate endocytosis pathways of gene carriers to improve gene delivery efficacy are elaborately described. Lastly, the perspectives of future studies to control endocytosis mechanisms are discussed to design potential non-viral gene vectors for active application in future.

摘要

非病毒载体能够调节细胞摄取途径,成为将基因高效转入细胞的有前途的载体,因为基因的细胞内处理强烈取决于内化途径和随后的细胞内途径。根据内吞作用机制,基因的细胞内处理可以定向到消化或非消化途径。已经进行了大量的尝试来绕过或避免溶酶体降解的消化途径,以在靶部位有意义地递送达治疗基因。本文综述了有关细胞内运输过程中内吞作用途径的调节以及初始内化途径的决定因素的最新信息,这对于合理设计非病毒基因载体具有重要意义。首先,我们描述了各种非病毒基因载体和非病毒基因转移的关键障碍。其次,讨论了各种主要的内吞作用途径及其在开发非病毒基因载体中的意义。第三,详细描述了可以调节基因载体的内吞作用途径以提高基因传递效率的各种因素。最后,讨论了控制内吞作用机制的未来研究的展望,以设计有潜力的非病毒基因载体,为未来的积极应用做好准备。

相似文献

1
Regulation of endocytosis by non-viral vectors for efficient gene activity.非病毒载体对基因活性的高效内吞作用的调控。
J Biomed Nanotechnol. 2014 Jan;10(1):67-80. doi: 10.1166/jbn.2014.1682.
2
Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.通过网格蛋白介导的内吞作用,靶向聚乳酸-聚乙二醇纳米粒增强 CD13 阳性血管内皮细胞的基因转染效率。
J Control Release. 2011 Apr 30;151(2):162-75. doi: 10.1016/j.jconrel.2011.02.027. Epub 2011 Mar 3.
3
Intracellular barriers to non-viral gene transfer.非病毒基因转移的细胞内屏障
Curr Gene Ther. 2002 May;2(2):183-94. doi: 10.2174/1566523024605609.
4
Pharmaceutical strategies enhancing cell penetration efficiencies of non-viral gene delivery systems.增强非病毒基因传递系统细胞穿透效率的药物策略。
Curr Gene Ther. 2009 Aug;9(4):267-90. doi: 10.2174/156652309788921053.
5
Endocytosis in gene therapy with non-viral vectors.非病毒载体基因治疗中的内吞作用。
Wien Med Wochenschr. 2016 May;166(7-8):227-35. doi: 10.1007/s10354-016-0450-5. Epub 2016 May 3.
6
Selective stimulation of caveolae-mediated endocytosis by an osmotic polymannitol-based gene transporter.基于渗透压多甘露醇的基因转导体对 caveolae 介导的内吞作用的选择性刺激。
Biomaterials. 2012 Oct;33(29):7272-81. doi: 10.1016/j.biomaterials.2012.06.037. Epub 2012 Jul 19.
7
Intracellular trafficking of nonviral vectors.非病毒载体的细胞内运输
Gene Ther. 2005 Dec;12(24):1734-51. doi: 10.1038/sj.gt.3302592.
8
Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.网格蛋白介导的内吞作用和小窝蛋白介导的内吞作用在脂质体和多聚体介导的基因转移中的作用
Mol Ther. 2005 Sep;12(3):468-74. doi: 10.1016/j.ymthe.2005.03.038.
9
Cellular endocytosis and gene delivery.细胞内吞作用与基因递送。
Mol Med. 2010 May-Jun;16(5-6):222-9. doi: 10.2119/molmed.2009.00101. Epub 2010 Feb 3.
10
Enhance transgene responses through improving cellular uptake and intracellular trafficking by bio-inspired non-viral vectors.通过生物启发的非病毒载体提高细胞摄取和细胞内转运来增强转基因反应。
J Nanobiotechnology. 2020 Jan 31;18(1):26. doi: 10.1186/s12951-020-0582-z.

引用本文的文献

1
Engineering polyphenol-based carriers for nucleic acid delivery.基于多酚的工程化载体用于核酸递送。
Theranostics. 2023 May 21;13(10):3204-3223. doi: 10.7150/thno.81604. eCollection 2023.
2
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.
3
Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues.基于脂质体的原位基因递送方法用于将视网膜和大脑皮层作为免疫赦免组织。
Pharmaceutics. 2020 Feb 25;12(3):198. doi: 10.3390/pharmaceutics12030198.
4
A Non-Viral Plasmid DNA Delivery System Consisting on a Lysine-Derived Cationic Lipid Mixed with a Fusogenic Lipid.一种由赖氨酸衍生的阳离子脂质与促融合脂质混合而成的非病毒质粒DNA递送系统。
Pharmaceutics. 2019 Nov 27;11(12):632. doi: 10.3390/pharmaceutics11120632.
5
Current trends in targeted therapy for drug-resistant infections.耐药感染的靶向治疗的当前趋势。
Appl Microbiol Biotechnol. 2019 Oct;103(20):8301-8314. doi: 10.1007/s00253-019-10028-5. Epub 2019 Aug 14.
6
Novel cholesterol-based cationic lipids as transfecting agents of DNA for efficient gene delivery.新型胆固醇基阳离子脂质作为DNA转染剂用于高效基因递送。
Int J Mol Sci. 2015 Mar 11;16(3):5666-81. doi: 10.3390/ijms16035666.